Skip to main content

Table 1 Effects of matrix metalloprotease and secretory pathway inhibitors on GP1 shedding and cytotoxicty in HEK-293T/17 cells

From: Characterization of the Lassa virus GP1 ectodomain shedding: implications for improved diagnostic platforms

inhibitor

[] in assay

Notes/references

effect on GP1 shedding

cytotox.(MTT)

morphology (microscopy)

2,2 dipyridyl

1 μM

Calbiochem

-

-

enlarged cells

1,10 phenanthroline

10 μM

ref. [12]

-

-

detached cells

bestatin

10 μM

1 - 10 μM working []

-

-

enlarged cells

α1-antichymotrypsin

4 μM

ref. [12]

-

-

normal

phosphoramidon

10 μM

IC50 = 4.6 μM

-

-

enlarged cells

captopril

10 μM

ref. [12]

-

-

normal

MMP-9 inhibitor I

50 nM

IC50 = 5 nM

-

-

detached cells

MMP-2 inhibitor I

100 μM

Ki = 1.7 μM

-

+

enlarged cells

GM6001

5 μM

Ki = 400 pM - 27 nM

-

-

normal

TAPI-1

50 μM

IC50 = 100 nM

-

-

normal

EDTA

5 mM

1 - 10 mM working []

-

-

rounded cells

EGTA

5 mM

1 - 10 mM working []

-

-

rounded cells

brefeldin A

15 μg/mL

BD Golgi Plug™

+++

+

rounded cells

monensin

10 μM

BD Golgi Stop™

+++

+

rounded cells